• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病的神经病理学诊断。

The neuropathological diagnosis of Alzheimer's disease.

机构信息

Department of Neuroscience, The Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.

出版信息

Mol Neurodegener. 2019 Aug 2;14(1):32. doi: 10.1186/s13024-019-0333-5.

DOI:10.1186/s13024-019-0333-5
PMID:31375134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6679484/
Abstract

Alzheimer's disease is a progressive neurodegenerative disease most often associated with memory deficits and cognitive decline, although less common clinical presentations are increasingly recognized. The cardinal pathological features of the disease have been known for more than one hundred years, and today the presence of these amyloid plaques and neurofibrillary tangles are still required for a pathological diagnosis. Alzheimer's disease is the most common cause of dementia globally. There remain no effective treatment options for the great majority of patients, and the primary causes of the disease are unknown except in a small number of familial cases driven by genetic mutations. Confounding efforts to develop effective diagnostic tools and disease-modifying therapies is the realization that Alzheimer's disease is a mixed proteinopathy (amyloid and tau) frequently associated with other age-related processes such as cerebrovascular disease and Lewy body disease. Defining the relationships between and interdependence of various co-pathologies remains an active area of investigation. This review outlines etiologically-linked pathologic features of Alzheimer's disease, as well as those that are inevitable findings of uncertain significance, such as granulovacuolar degeneration and Hirano bodies. Other disease processes that are frequent, but not inevitable, are also discussed, including pathologic processes that can clinically mimic Alzheimer's disease. These include cerebrovascular disease, Lewy body disease, TDP-43 proteinopathies and argyrophilic grain disease. The purpose of this review is to provide an overview of Alzheimer's disease pathology, its defining pathologic substrates and the related pathologies that can affect diagnosis and treatment.

摘要

阿尔茨海默病是一种进行性神经退行性疾病,最常与记忆缺陷和认知能力下降有关,但越来越多的人认识到不太常见的临床表现。这种疾病的主要病理特征已经存在了一百多年,今天,这些淀粉样斑块和神经原纤维缠结仍然是病理诊断所必需的。阿尔茨海默病是全球最常见的痴呆症病因。除了少数由基因突变驱动的家族病例外,绝大多数患者仍然没有有效的治疗选择,而且除了少数家族病例外,这种疾病的主要病因仍不清楚。导致开发有效的诊断工具和疾病修饰疗法的努力受到阻碍的原因是,人们意识到阿尔茨海默病是一种混合性蛋白病(淀粉样蛋白和tau 蛋白),经常与其他与年龄相关的过程(如脑血管疾病和路易体疾病)相关。定义各种共病之间的关系和相互依存性仍然是一个活跃的研究领域。这篇综述概述了与阿尔茨海默病病因相关的病理特征,以及那些不可避免但意义不明的发现,如颗粒空泡变性和 Hirano 小体。还讨论了其他经常发生但并非不可避免的疾病过程,包括在临床上可能模仿阿尔茨海默病的病理过程。这些包括脑血管疾病、路易体疾病、TDP-43 蛋白病和嗜银颗粒病。本文综述的目的是提供阿尔茨海默病病理学概述,其定义性病理底物以及可能影响诊断和治疗的相关病理学。

相似文献

1
The neuropathological diagnosis of Alzheimer's disease.阿尔茨海默病的神经病理学诊断。
Mol Neurodegener. 2019 Aug 2;14(1):32. doi: 10.1186/s13024-019-0333-5.
2
Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.神经退行性疾病伴随的蛋白病普遍存在,与年龄相关,与 APOE4 相关。
Brain. 2018 Jul 1;141(7):2181-2193. doi: 10.1093/brain/awy146.
3
Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.经前瞻性研究且尸检确诊为路易体痴呆患者精神症状的神经病理学基础
Am J Psychiatry. 2004 May;161(5):843-9. doi: 10.1176/appi.ajp.161.5.843.
4
What is 'Alzheimer's disease'? The neuropathological heterogeneity of clinically defined Alzheimer's dementia.什么是“阿尔茨海默病”?临床上定义的阿尔茨海默病痴呆的神经病理学异质性。
Curr Opin Neurol. 2021 Apr 1;34(2):237-245. doi: 10.1097/WCO.0000000000000912.
5
Neuropathological assessment of the Alzheimer spectrum.阿尔茨海默病谱系的神经病理学评估。
J Neural Transm (Vienna). 2020 Sep;127(9):1229-1256. doi: 10.1007/s00702-020-02232-9. Epub 2020 Aug 1.
6
Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.溶酶体组织蛋白酶 D 在阿尔茨海默病患者新皮质中上调,可能是神经纤维缠结变性的标志物。
Brain Pathol. 2019 Jan;29(1):63-74. doi: 10.1111/bpa.12631. Epub 2018 Oct 17.
7
Low amyloid (Abeta) plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain disease from Alzheimer's disease.低淀粉样蛋白(β-淀粉样蛋白)斑块负荷以及弥漫性斑块的相对优势可将嗜银颗粒病与阿尔茨海默病区分开来。
Neuropathol Appl Neurobiol. 1999 Aug;25(4):295-305. doi: 10.1046/j.1365-2990.1999.00175.x.
8
Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease.阿尔茨海默病患者经淀粉样蛋白-β免疫接种 14 年后仍存在神经病理学影响。
Brain. 2019 Jul 1;142(7):2113-2126. doi: 10.1093/brain/awz142.
9
The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer's Dementia Using the NACC Database.利用 NACC 数据库探讨脑血管病理学对阿尔茨海默病轻度阶段的影响。
Curr Alzheimer Res. 2020;17(13):1167-1176. doi: 10.2174/1567205018666210212160902.
10
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.突触核蛋白病生存及痴呆症发病的神经病理学和遗传学关联:一项回顾性分析
Lancet Neurol. 2017 Jan;16(1):55-65. doi: 10.1016/S1474-4422(16)30291-5.

引用本文的文献

1
Quantification of monoamine oxidase B expression with C-SL25.1188 for imaging reactive astrocytes in patients with Alzheimer's disease.使用C-SL25.1188对单胺氧化酶B表达进行定量分析,以对阿尔茨海默病患者的反应性星形胶质细胞进行成像。
Eur J Nucl Med Mol Imaging. 2025 Sep 6. doi: 10.1007/s00259-025-07542-2.
2
Down syndrome and a presenilin 2 variant: dual genetic risk of Alzheimer's disease.唐氏综合征与早老素2变异体:阿尔茨海默病的双重遗传风险
Acta Neuropathol. 2025 Sep 4;150(1):24. doi: 10.1007/s00401-025-02931-1.
3
Privacy-preserving dementia classification from EEG via hybrid-fusion EEGNetv4 and federated learning.

本文引用的文献

1
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.全基因组荟萃分析确定了新的位点和功能途径,影响阿尔茨海默病的风险。
Nat Genet. 2019 Mar;51(3):404-413. doi: 10.1038/s41588-018-0311-9. Epub 2019 Jan 7.
2
Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease.年龄和疾病依赖性磷酸泛素化标志在正常衰老和路易体病中的增加。
Autophagy. 2018;14(8):1404-1418. doi: 10.1080/15548627.2018.1461294. Epub 2018 Jul 28.
3
Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's disease.
通过混合融合EEGNetv4和联邦学习实现基于脑电图的隐私保护痴呆症分类
Front Comput Neurosci. 2025 Aug 18;19:1617883. doi: 10.3389/fncom.2025.1617883. eCollection 2025.
4
Pathology-Specific Modulation of Corticostriatal Circuitry by Chronic Alcohol Consumption in Alzheimer's Disease Mouse Models.阿尔茨海默病小鼠模型中慢性酒精摄入对皮质纹状体回路的病理学特异性调节
bioRxiv. 2025 Aug 21:2025.08.15.670607. doi: 10.1101/2025.08.15.670607.
5
Advancements in extracellular vesicle therapy for neurodegenerative diseases.用于神经退行性疾病的细胞外囊泡疗法的进展。
Explor Neuroprotective Ther. 2025;5. doi: 10.37349/ent.2025.1004104. Epub 2025 May 6.
6
Computational prediction of high-risk non-synonymous SNPs in human ApoE and their structural impact on amyloid-β interaction in Alzheimer's disease pathogenesis.人类载脂蛋白E中高风险非同义单核苷酸多态性的计算预测及其在阿尔茨海默病发病机制中对淀粉样β蛋白相互作用的结构影响
PLoS One. 2025 Sep 2;20(9):e0331339. doi: 10.1371/journal.pone.0331339. eCollection 2025.
7
Investigation into Efficacy and Mechanisms of Neuroprotection of Ashwagandha Root Extract and Water-Soluble Coenzyme Q10 in a Transgenic Mouse Model of Alzheimer's Disease.在阿尔茨海默病转基因小鼠模型中对南非醉茄根提取物和水溶性辅酶Q10神经保护作用的疗效及机制研究
Nutrients. 2025 Aug 20;17(16):2701. doi: 10.3390/nu17162701.
8
and as Modifiers of Age of Onset in Autosomal-Dominant Early-Onset Alzheimer's Disease Caused by the A431E Variant.以及作为由A431E变体引起的常染色体显性早发性阿尔茨海默病发病年龄的修饰因子。
Int J Mol Sci. 2025 Aug 16;26(16):7929. doi: 10.3390/ijms26167929.
9
Olfactory-Guided Behavior Uncovers Imaging and Molecular Signatures of Alzheimer's Disease Risk.嗅觉引导行为揭示阿尔茨海默病风险的成像和分子特征。
Brain Sci. 2025 Aug 13;15(8):863. doi: 10.3390/brainsci15080863.
10
Impact of Manganese on Neuronal Function: An Exploratory Multi-Omics Study on Ferroalloy Workers in Brescia, Italy.锰对神经元功能的影响:意大利布雷西亚铁合金工人的探索性多组学研究
Brain Sci. 2025 Jul 31;15(8):829. doi: 10.3390/brainsci15080829.
阿尔茨海默病中与 APP 基因的重复和错义突变、唐氏综合征和散发性阿尔茨海默病相关的血管淀粉样蛋白的模式和严重程度。
Acta Neuropathol. 2018 Oct;136(4):569-587. doi: 10.1007/s00401-018-1866-3. Epub 2018 May 16.
4
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.NIA-AA 研究框架:迈向阿尔茨海默病的生物学定义。
Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018.
5
Capillary cerebral amyloid angiopathy in Alzheimer's disease: association with allocortical/hippocampal microinfarcts and cognitive decline.阿尔茨海默病中的脑毛细血管淀粉样血管病:与皮质下/海马微梗死和认知衰退的关联。
Acta Neuropathol. 2018 May;135(5):681-694. doi: 10.1007/s00401-018-1834-y. Epub 2018 Mar 24.
6
Alzheimer's Disease-Related Dementias Summit 2016: National research priorities.2016年阿尔茨海默病相关痴呆症峰会:国家研究重点
Neurology. 2017 Dec 5;89(23):2381-2391. doi: 10.1212/WNL.0000000000004717. Epub 2017 Nov 8.
7
Alzheimer's disease.阿尔茨海默病。
Eur J Neurol. 2018 Jan;25(1):59-70. doi: 10.1111/ene.13439. Epub 2017 Oct 19.
8
Cerebral amyloid angiopathy as a cause of neurodegeneration.脑淀粉样血管病作为神经退行性变的病因。
J Neurochem. 2018 Mar;144(5):651-658. doi: 10.1111/jnc.14157. Epub 2017 Sep 21.
9
On the path to 2025: understanding the Alzheimer's disease continuum.通往2025之路:理解阿尔茨海默病连续体
Alzheimers Res Ther. 2017 Aug 9;9(1):60. doi: 10.1186/s13195-017-0283-5.
10
Cryo-EM structures of tau filaments from Alzheimer's disease.阿尔茨海默病tau蛋白细丝的冷冻电镜结构
Nature. 2017 Jul 13;547(7662):185-190. doi: 10.1038/nature23002. Epub 2017 Jul 5.